Microbial virulence may be the consequence of several properties, including the ability of certain species to resist, escape, or pervert host defense mechanisms. Such mechanisms have been implicated in the pathogenesis of several diseases, including measles (11) , influenza (1), leprosy (7) , candidiasis (9) , leishmaniasis (14) , trypanosomiasis (2), cryptococcosis (4), tuberculosis (12) , and syphilis (27) , among others. Perhaps the most prominent example of this relationship between host and pathogen is AIDS, where the causative virus infects and destroys a subpopulation of T lymphocytes. While the nature and contribution of the immune system to the pathogenesis of periodontal disease are poorly understood, recent studies suggest that the development of these disorders may be associated with immunologic dysfunction (reviewed in reference 16). Although the basis for this dysfunction is unclear, we have found that several putative periodontal pathogens are capable of inhibiting human lymphocyte responsiveness (17) (18) (19) (20) (21) . The ability of microorganisms to suppress the immune response of the host may affect the course of initial infection by facilitating spread, multiplication, and persistence and may lead to enhanced susceptibility to infection by secondary pathogens (reviewed in references 15 and 28) . Previously, we demonstrated that a nonoral isolate of Prevotella intermedia was capable of suppressing lymphocyte proliferation (22) . We have now extended these studies to include oral isolates of P. intermedia and to further characterize the immunosuppressive properties of this organism.
MATERIALS AND METHODS
Bacterial strains and culture conditions. The P. intermedia strains used in this study, M87-903, M87-679, M87-714, and M87-735, were fresh isolates from advanced periodontitis lesions of adult patients. The organisms were identified to species level by the methods of Holdeman et al. (5) . All strains were grown in 1-liter cultures in 85% N2-10% H2-5% ride.
Bacterial fractions were prepared as previously described (22) . Briefly, bacterial cells harvested from 1-liter cultures were washed, suspended in 20 ml of phosphate-buffered saline (PBS), and disrupted by sonication at 4°C for a total of 10 min with 1-min pulses in the presence of glass beads. After settling of the beads, unbroken cells and the membrane fraction were sedimented at 85,000 x g for 60 min. The protein that remained in suspension after high-speed centrifugation was designated the sonic extract (SE) and contained both cytoplasmic and periplasmic proteins. The SE was extensively dialyzed against PBS and then against RPMI 1640, and the protein concentration was determined by the Bio-Rad assay (Bio-Rad Laboratories, Richmond, Calif.) with bovine serum albumin as a standard.
Preparation of HPMC. Human peripheral blood mononuclear cells (HPMC) were prepared as described previously (23) . Briefly, HPMC were prepared from 100 to 200 ml of heparinized venous blood of healthy donors. The blood was first centrifuged at 300 x g for 15 min at 5°C; the plasma was then removed, and the cells were brought back to the original volume with Hanks balanced salt solution (HBSS). HPMC were then isolated by buoyant density centrifugation on Ficoll-Hypaque (Pharmacia LKB Biotechnology, Piscataway, N.J.). The HPMC were washed twice with HBSS and diluted to 2 x 106 viable cells per ml of HBSS. Viable cell counts were performed by assessing trypan blue exclusion.
Purified populations of lymphocytes and monocytes were obtained by counterflow centrifugal elutriation as previously described (23) . HPMC (2 x 108 to 4 x 108) were suspended in 20 ml of HBSS-CaMg containing 0.5% bovine serum albumin (BSA) and pumped into a Beckman elutriator rotor (model JE-6 rotor equipped with a standard chamber; Beckman Instruments, Fullerton, Calif.); the flow rate was 7 ml/min, and the rotor speed was 1,960 rpm. This initial flow 4583 on October 28, 2017 by guest http://iai.asm.org/ Downloaded from rate permitted the mononuclear cells in the horizontal chamber to stratify by size and density while contaminating platelets were removed. Cells were then eluted by sequentially increasing the flow rate; lymphocytes were obtained at a flow rate of 7 to 12 ml/min, while monocytes were eluted at 14 to 16 ml/min. All fractions were counted, and their size distribution was monitored on a model ZBI Coulter Counter connected to an IBM personal computer with appropriate hardware and software (Personal Computer Analyzer; Nucleus Inc., Oak Ridge, Tenn.). Cells were stained with anti-CD3 (Ortho Diagnostic Systems, Raritan, N.J.), antihuman immunoglobulin (Ig) (Southern Biotechnology Associates, Birmingham, Ala.), and anti-LeuM3 (Becton Dickinson Immunocytometry Systems, San Jose, Calif.) antibodies conjugated with fluorescein isothiocyanate, and purity was assessed by immunofluorescence and fluorescence-activated cell sorter analysis. The lymphocyte and monocyte preparations were routinely found to be >98% and 85 to 95% pure, respectively. T cells were further purified by E-rosette formation. Briefly, sheep erythrocytes were washed and treated with 0.14 M 2-aminoethylisothiouronium bromide at pH 9 for 15 min. After the cells were washed four times, sheep erythrocytes and lymphocytes (isolated by counterflow centrifugal elutriation) were pelleted and incubated together for 60 min. The cells were then gently resuspended; nonrosetted cells were separated from rosetted cells by centrifugation on Ficoll-Hypaque (see above). The rosetted cells in the pellet were lysed to remove sheep erythrocytes and found to contain >98% T cells when stained with anti-CD3 monoclonal antibody and analyzed by flow cytometry.
Assays of mitogen-induced DNA, RNA, and protein synthe-
ses. An HPMC suspension (0.1 ml) containing 2 x 105 cells was placed into each well of flat-bottom microculture plates. Each culture received 0.1 ml of medium (as described above) or various concentrations of SE diluted in medium and sterilized by passage through a 0. were all of the IgG1 isotype. After 30 min on ice, the cells were washed three times and fixed overnight in 1% paraformaldehyde. Cells were examined for fluorescence staining with a fluorescence-activated cell sorter (FACStarPlus flow cytometer; Becton Dickinson Immunocytometry Systems). The flow cytometer was equipped with logarithmic amplifiers for fluorescence measurements. Fluorescein isothiocyanate was excited by an argon laser at 488 nm (200 mW), and its fluorescence was measured through a 515-to 540-nm bandpass filter. Ten thousand cells were examined for each sample; cells which gave fluorescence signals brighter than those seen on 95 to 99% control cells were considered to be positive. Data were analyzed on a HewlettPackard computer (Hewlett-Packard, Sunnyvale, Calif.).
Ion-exchange chromatography. After dialysis against 10 mM Tris buffer (pH 7.0) containing 10 mM NaCl and 1 mM EDTA, the SE was applied to a Mono Q column (0.5 by 5 cm; Pharmacia LKB Biotechnology) preequilibrated in this buffer. The column was then extensively washed and eluted with a linear NaCl gradient (10 mM to 0.5 M) at a flow rate of 1 ml/min. Fractions (1 ml) were collected and monitored for both A280 and for immunosuppressive potential at multiple dilutions. This allowed calculation of 50% infective dose (ID50) units per milliliter by determining the amount of sample (in microliters) required to reduce [3H]TdR incorporation to 50% of control values. Appropriate fractions were pooled and concentrated by membrane ultrafiltration (YM-10 and Centricon 10; Amicon, Lexington, Mass.).
Gel filtration chromatography. Pooled and concentrated fractions from ion-exchange chromatography were further fractionated by gel filtration chromatography on a Superose 12 column (Pharmacia). The column was equilibrated with PBS; a 200-,ul sample was applied, and 0.5-ml fractions were collected. All fractions were monitored for A280 and for their ability to suppress lymphocyte proliferation.
RESULTS
Bacterial extracts were first evaluated for their ability to alter HPMC responses to several mitogens, including PHA, ConA, PWM, and S. aureus. As shown in Fig. 1 , all four strains were capable of inhibiting mitogen-induced [3H]TdR incorporation. Responses to all four mitogens were inhibited in a dose-dependent fashion; PWM-and S. aureus-induced activations were consistently found to be more sensitive to the inhibitory effects of the P. intermedia SEs than activation induced by either PHA or ConA. As shown in Table 1 of control values) were lower for PWM and S. aureus than those observed when either PHA or ConA was employed as the mitogenic stimulant. This difference in sensitivity may, in part, reflect differences in cell susceptibility to the SE since PWM and S. aureus predominantly activate B cells and PHA and ConA activate T cells. These inhibitory effects were not simply due to cell death; the SE had no effect on cell viability, as evidenced by trypan blue exclusion at the concentrations employed. In addition to mitogen responsiveness, antigenic responses to tetanus toxoid and streptokinase/streptodornase were similarly inhibited (data not shown).
Experiments were also performed to determine if the four SEs could suppress other parameters of lymphocyte activation. Figure 2 shows the results of experiments in which RNA and protein syntheses were assessed in HPMC after exposure to SE and ConA. These results clearly indicate that both metabolic processes were inhibited, with RNA synthesis being more sensitive than protein synthesis. Not returned to culture. These results suggest that P. intermedia affects the early stages of cell activation. This conclusion is further supported by the finding that the P. intermedia SEs also inhibit the production and expression of IL-2 and its receptor (IL-2R) on T cells. T-cell activation has been found to be dependent upon the synthesis and secretion of these molecules during the first 24 to 48 h after exposure to mitogen or antigen (3) . As shown in Table 3 , P. intermedia M87-903 caused a dose-dependent reduction in PHA-induced cytokine production. Similar results were observed with the other three strains of P. intermedia. Figure 4 demonstrates the effect of P. intermedia M87-903 on PHA-induced expression of IL-2R and CD69 (Leu23). As indicated above, expression of IL-2R is an early requisite of T-cell activation. CD69 is a phosphorylated 28-to 32-kDa disulfide-linked homodimer expressed on the surface of activated T cells, B cells, and NK cells (26) . This surface marker is expressed 2 to 24 h after stimulation and has been proposed as an early marker of cell activation. The SE caused a reduction in the percentage of cells expressing IL-2R from 40% (PHA control) to 22% (SE treated). In those cells still expressing IL-2R after exposure to P. intermedia, the surface density of the receptor was reduced, as evidenced by a decrease in the fluorescence intensity. Likewise, the SE caused a reduction in the percentage of cells expressing CD69, from 49% in PHA-treated cells to 21% in cells exposed to the bacterial extract.
Preliminary studies have been carried out to determine the physicochemical characteristics of the P. intermedia suppressive substance. The inhibitory activity was found to be temperature sensitive (Fig. 5) , with partial degradation (or neutralization) of the inhibitor occurring after a 30-min exposure to a temperature of 56°C and total destruction after exposure to 85°C. The crude SE was also fractionated by ion-exchange chromatography (Mono Q); the activity bound to the column and could be eluted with -0.2 M NaCl (Fig.  6) . The active fractions were pooled, concentrated, and applied to a Superose 12 gel filtration column. As shown in Fig. 7 , the suppressive activity appeared in one well-defined peak corresponding to a molecular mass of approximately 50 kDa.
DISCUSSION
In previous studies, we demonstrated that SE prepared from P. intermedia, Porphyromonas asaccharolytica, Porphorymonas endodontalis, and Prevotella melaninogenica were capable of suppressing human T-and B-cell responsiveness (22) . This report extends those observations to include assessment of the immunomodulatory capability of oral isolates of P. intermedia and to further characterize the inhibitory effects. All four P. intermedia strains inhibited mitogen (and antigen)-induced activation of both human B and T cells. Inhibition was dose dependent, and B cell responsiveness (to PWM and S. aureus) was found to be considerably more sensitive to the bacterial extracts than were T cells (to ConA and PHA). Suppression was reflected in altered protein, RNA, and DNA syntheses. Preliminary characterization suggests that the immunosuppressive activity is nondialyzable and heat labile, with activity being completely destroyed at 85°C. Gel filtration chromatography of active material eluted from an ion-exchange column yielded a single, well-defined peak of inhibitory activity corresponding to a molecular mass of 55 kDa. Microbial products represent an important source of immunoregulatQry, agents. In particular, several microorganisms are capable of suppressing the inmmune response through various products, including toxins, enzymes, cell wall components, and metabolites (for reviews, see references 15 and 28) . These immunosuppressive products may alter the immune system via different mechanisms. In some instances these agents indirectly modify lymphocyte responsiveness by directly affecting monocyte or macrophage activities. For example, Treponema denticola, Treponema pallidum, and Corynebacterium parvum provoke the release of hydrogen peroxide, prostaglandin, and other mediators capable of inhibiting lymphocyte function (10, 20, 27) . Other organisms such as Leishmania donovani impair the synthesis and release of IL-1 from macrophages (14) . Recently, we have demonstrated that a toxin produced by Actinobacillus actinomycetemcomitans, a periodontal pathogen, is capable of impairing lymphocyte responsiveness by selectively killing monocytes (13) . In addition to affecting monocytes, several microorganisms interact directly with lymphocytes, resulting in nonspecific inhibition of their activation and/or proliferation. For example, cholera toxin interacts with lymphocytes in vitro and in vivo and activates adenylate cyclase which results in intracellular accumulation of cyclic AMP (6, 24) . Trypanosoma cruzi, on the other hand, has been shown to impair lymphocyte activation by interfering with IL-2R expression (2 tion. Our current observations do suggest direct effects on the early stages of T-cell activation as evidenced by a reduction in IL-2 (and/or IL-4) production and by the expression of IL-2R and CD69. The role and requirement for IL-2 in the activation of lymphocytes (both B and T) is well established (25) . Likewise, the importance of expression of IL-2R during the early stages of the activation process has been documented (3). IL-2 plays an important role in paracrine and autocrine regulatory processes and thereby influences the expression of IL-2R (3). Therefore, the ability of P. intermedia to impair the production of both IL-2 and IL-2R should account for the observed suppression of T-and B-cell activation and proliferation. At this point, the actual mechanism by which P. intermedia impairs the expression of these proteins is not known. While IL-1 has been shown to be critical for the production of these regulatory proteins, preliminary studies do not indicate a role for the monocyte in mediating the suppressive effects of P. intermedia. Studies are currently under way to determine if the primary effect of P. intermedia involves IL-2 or some preceding event that ultimately results in reduced production of IL-2, IL-2R, and CD69. In this regard, expression of these proteins has been linked to early events of lymphocyte activation associated with membrane signal transduction such as Ca2+ influx, protein kinase C activation, or both (26) .
In conclusion, the ability of microorganisms to modulate in vivo and in vitro immunological responsiveness is an established phenomenon. The exact contribution of these exogenous regulatory processes to periodontal disease remains to be determined. Our current finding that P. intermedia inhibits the immune response suggests that impaired host defense mechanisms may contribute to the disease process. Such inhibitory factors could lead to a state of immunological hyporesponsiveness that favors colonization by the initiating organism or by other opportunistic organisms.
